Healthcare Industry – Market Update from 14 – 19 September 2020

1.  Servier participates at the leading European congress on Oncology from September 14 to October 18. Servier will reinforce its commitment to support the patients and their family with 2 digital platformsServier and WeHealth TM Digital Medicine. The Servier virtual booth will provide medical education and information in colorectal, gastric and pancreatic cancers as well as haematological malignancies to healthcare professionals (HCPs).
👉 More details: Here
2. The U.S. Food and Drug Administration – FDA grants Dupixent® (dupilumab) Breakthrough Therapy designation for eosinophilic esophagitis. Dupixent is the first and only biologic to show positive and clinically-meaningful Phase 3 results in patients 12 years and older with eosinophilic esophagitis (EoE). Designation supports Dupixent’s potential in another disease driven by type 2 inflammation.

👉 More details: Here

3. Oncology Hospital in Ho Chi Minh City has just launched the tele-care system (Telehealth). This is one of 24 higher-level hospitals in the country appointed by the Ministry of Health to participate in the project “Remote examination and treatment in the period 2020-2025”.
👉 More details: Here
We do hope those information helps you to update industry movement.
ASHAVI – Your Research Friend, will inform you about market and industry change. Our specialties are Market Research and Technology.
You win, we are happy. Wish you all the best.

ASHAVI – Boost Business By Insights and Technologies

Get in touch with us contact@ashavi.com | Follow us via